TrialLeukemia2015

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.

J Peccatori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.